Kerbauy, Lucila; Okamoto, Oswaldo Keith 
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: IB
Subjects: CÉLULAS, VETORES, CULTURA DE CÉLULAS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KERBAUY, Lucila e OKAMOTO, Oswaldo Keith. Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia. Blood. Washington: Instituto de Biociências, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-170045. Acesso em: 04 jun. 2024. , 2022APA
Kerbauy, L., & Okamoto, O. K. (2022). Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia. Blood. Washington: Instituto de Biociências, Universidade de São Paulo. doi:10.1182/blood-2022-170045NLM
Kerbauy L, Okamoto OK. Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia [Internet]. Blood. 2022 ; 40( 1):[citado 2024 jun. 04 ] Available from: https://doi.org/10.1182/blood-2022-170045Vancouver
Kerbauy L, Okamoto OK. Clinical validation of automated manufacture of autologous CD19 CAR-T cells for treatment of B neoplasia [Internet]. Blood. 2022 ; 40( 1):[citado 2024 jun. 04 ] Available from: https://doi.org/10.1182/blood-2022-170045
